Scholarlink

<p>Paralogous genes challenge short-read sequencing (SRS) due to high sequence similarity. Although long-read sequencing (LRS) improves resolution, the extent to which it resolves paralogous genes remains unclear. This study evaluates the capability of LRS by integrating in silico mappability-based predictions with clinical data to generate SRS- and LRS-unresolved gene lists, and by assessing whether a paralog-specific phasing, Paraphase, can overcome remaining limitations. Mappability was simulated across read lengths (250 bp to 14 kb) to predict unresolved regions and validated against mapping quality (MQ) from 66 high-fidelity LRS samples. Paraphase was applied to 79 paralog groups. Among 645 medically relevant (MR) genes unresolved by SRS, 419 (65.0%) were predicted to be resolved by LRS, while 226 (35.0%) remained unresolved. These predictions correlated with clinical MQ (<i>χ</i>² = 92.43, <i>p</i> &lt; 2.2 × 10<sup>−16</sup>; <i>κ</i> = 0.37), with significant differences between LRS-resolved and LRS-unresolved MR genes (<i>W</i> = 63,656, <i>p</i> &lt; 2.2 × 10<sup>−16</sup>; <i>r</i> = 0.36). Paraphase resolved 61 groups (77.2%), providing additional resolution beyond LRS. LRS improves paralogous gene resolution but cannot fully eliminate paralog blind spots. Curated gene lists define boundaries of LRS utility for clinical interpretation, while Paraphase adds complementary resolution, supporting an integrated framework combining predictive modeling with algorithmic strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrative analysis of in silico predictions and clinical evidence to delineate the capability of HiFi long-read sequencing in paralogous genes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月3日

查看全文
  • Sung Kyung Kim,
  • Joowon Jang,
  • Yeseul Kim,
  • Hobin Sung,
  • Hyesu Lee,
  • Hara Yim,
  • Sung Im Cho,
  • Jee-Soo Lee,
  • Moon-Woo Seong

摘要

Paralogous genes challenge short-read sequencing (SRS) due to high sequence similarity. Although long-read sequencing (LRS) improves resolution, the extent to which it resolves paralogous genes remains unclear. This study evaluates the capability of LRS by integrating in silico mappability-based predictions with clinical data to generate SRS- and LRS-unresolved gene lists, and by assessing whether a paralog-specific phasing, Paraphase, can overcome remaining limitations. Mappability was simulated across read lengths (250 bp to 14 kb) to predict unresolved regions and validated against mapping quality (MQ) from 66 high-fidelity LRS samples. Paraphase was applied to 79 paralog groups. Among 645 medically relevant (MR) genes unresolved by SRS, 419 (65.0%) were predicted to be resolved by LRS, while 226 (35.0%) remained unresolved. These predictions correlated with clinical MQ (χ² = 92.43, p < 2.2 × 10−16; κ = 0.37), with significant differences between LRS-resolved and LRS-unresolved MR genes (W = 63,656, p < 2.2 × 10−16; r = 0.36). Paraphase resolved 61 groups (77.2%), providing additional resolution beyond LRS. LRS improves paralogous gene resolution but cannot fully eliminate paralog blind spots. Curated gene lists define boundaries of LRS utility for clinical interpretation, while Paraphase adds complementary resolution, supporting an integrated framework combining predictive modeling with algorithmic strategies.